Chronic heart failure: current evidence, challenges to therapy, and future directions. - Wikidata - awgldk - TriplyDB

Chronic heart failure: current evidence, challenges to therapy, and future directions.

Chronic heart failure: current evidence, challenges to therapy, and future directions.

http://www.wikidata.org/entity/Q37880858

about

Role of the carotid body in the pathophysiology of heart failure Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.Depression is associated with cognitive dysfunction in older adults with heart failure.Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure.Retraction. rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis.Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells.Thyroid hormone and cardiac repair/regeneration: from Prometheus myth to reality?Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis.Prognostic relevance of heart rate at rest for survival and the quality of life in patients with dilated cardiomyopathy.Innovative Telemonitoring Enhanced Care Programme for Chronic Heart Failure (ITEC-CHF) to improve guideline compliance and collaborative care: protocol of a multicentre randomised controlled trial.NS5806 partially restores action potential duration but fails to ameliorate calcium transient dysfunction in a computational model of canine heart failure.CHF-PROM: validation of a patient-reported outcome measure for patients with chronic heart failure.Effect of heart failure reversal treatment as add-on therapy in patients with chronic heart failure: A randomized, open-label study.Self-emulsifying drug delivery system improves preventive effect of curcuminoids on chronic heart failure in rats.

P2860

Q26853502-53B25527-6FD8-44DD-B43C-3F15521BB960 Q30539892-0F19CE54-6B32-4B01-859A-D096F3E3149C Q35614944-23492C8D-5CF9-49DA-B32C-F1F522C2D1A3 Q35667909-903E29FA-2FC8-432B-8ACA-93A3BAD511E8 Q36410248-3086E8BA-DBB1-4701-9DCC-48AAE2EC66A6 Q37571935-E6A1ED1B-C738-44D6-AF50-1A1575713F32 Q38023872-626667E1-961B-4CF1-AD58-A82E90CBC858 Q38540286-2D6655DF-6F39-48BC-9673-7397F756D8AD Q38546917-3A48379F-0B35-4199-B5C3-5E51AB385375 Q39012062-6A06AAD5-05E9-4A77-811E-9BDA281DA630 Q39635805-0D45302B-35CB-414F-BC45-B3BF79FDEB25 Q42376830-AD81DC7C-74B2-4366-B000-539041FC36B3 Q51017612-DD14F601-CFB0-4D3D-B4D5-CE2EDE73680E Q52648355-DCAAAA27-4C35-4FC2-8D50-920158F71511 Q54954296-9760E5D8-70E0-4DA6-9DA1-8F7E62CD80DB Q55121623-2591062A-40A7-4586-B346-DEB1D61B3952

P2860

Chronic heart failure: current evidence, challenges to therapy, and future directions.

http://www.wikidata.org/entity/Q37880858

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Chronic heart failure: current evidence, challenges to therapy, and future directions.

@en

Chronic heart failure: current evidence, challenges to therapy, and future directions.

@nl

type

label

Chronic heart failure: current evidence, challenges to therapy, and future directions.

@en

Chronic heart failure: current evidence, challenges to therapy, and future directions.

@nl

prefLabel

Chronic heart failure: current evidence, challenges to therapy, and future directions.

@en

Chronic heart failure: current evidence, challenges to therapy, and future directions.

@nl

P1433

Q37880858-CB51AE05-BE98-4B04-9726-F35A43C2DBC3

P1476

Q37880858-5DB355E7-BDC8-445E-8225-A7CDE038F2D4

P2093

Q37880858-1AE74402-8D64-4601-92D2-E28BB2AC97DD

Q37880858-28D036DD-EBBA-41C9-AB8D-30340F27D673

Q37880858-33F47D15-AA50-4F87-800F-07E1957E822F

P2860

Q37880858-04AD0AE7-6DF3-48D9-89A4-31A1BF03A0A8

Q37880858-073601D2-ED43-43AD-A287-3F862267E252

Q37880858-094317D4-BFA8-4402-A3B5-FDFF4662B29D

Q37880858-0D11B290-49BA-4E1E-9744-6CEA584C6488

Q37880858-0F8C66D7-3BFE-4439-96C9-F5C4236D6DDC

Q37880858-103E3210-59C8-4318-83EF-5F12001C5E4F

Q37880858-10721B8C-92A8-4563-8765-F914F2520BBA

Q37880858-1208CD97-8736-482E-B0B7-741A8F287297

Q37880858-14E51B8B-F6D6-4DEF-BBCA-3A081E6B4136

Q37880858-151E45ED-F6ED-4D71-8F10-82320DCF8942

P2888

Q37880858-6A08B1AD-3AE0-4CFC-8ABB-BFE3136592B6

P304

Q37880858-C2283F0B-AFE1-4597-B477-2202DF4C3633

P31

Q37880858-DAEDC200-2819-4221-B09C-50F945E1D3D7

P356

Q37880858-38C47CD6-49AB-4E42-BC2D-2C772C22BDE5

P433

Q37880858-4D821864-047A-4D29-8E02-AE6BAFE575B0

P478

Q37880858-D656574B-5CA9-4A82-B07B-226BC9050765

P577

Q37880858-02408BB8-938A-47B4-B429-CA0F01D42962

P5875

Q37880858-33F20281-34EF-498F-8EBB-B388F5195BBD

P6179

Q37880858-8E1C986B-05B8-4515-A5A5-6B46D9A02577

P698

Q37880858-C8915624-04B1-4B67-8F35-134A6A15E0A2

P921

Q37880858-B726265F-04E4-4BBA-B74F-F4610A71C817

P356

11592090-000000000-00000

P1433

American journal of cardiovascular drugs

P1476

Chronic heart failure: current evidence, challenges to therapy, and future directions.

@en

P2093

Lawrence Czer

http://www.w3.org/2001/XMLSchema#string

Prediman K Shah

http://www.w3.org/2001/XMLSchema#string

Ryan P Morrissey

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

Adverse events associated with testosterone administration

Chocolate intake and incidence of heart failure: a population-based prospective study of middle-aged and elderly women

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

Increased mortality after dronedarone therapy for severe heart failure

The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study

P2888

11592090-000000000-00000

P304

153-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11592090-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51171695

http://www.w3.org/2001/XMLSchema#string

P6179

1041579575

http://www.w3.org/2001/XMLSchema#string

P698

21619379

http://www.w3.org/2001/XMLSchema#string

P921